Orient Technologies (NSE: ORIENTTECH) Q3 FY26 results: Why short-term margin pain may be the price of securing long-cycle government and services revenue
Read More 4 minute read Pharma Industry News Bausch + Lomb closes €675m secured notes offering and expands credit agreement with new $2.325bn term loan facility Bausch + Lomb finalizes €675M notes offering and $2.325B loan refinancing to optimize debt structure and support future eye health innovation. byPallavi MadhirajuJuly 1, 2025